Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Pancreatic Adenocarcinoma, Version 1.2019.

Tempero MA, Malafa MP, Chiorean EG, Czito B, Scaife C, Narang AK, Fountzilas C, Wolpin BM, Al-Hawary M, Asbun H, Behrman SW, Benson AB, Binder E, Cardin DB, Cha C, Chung V, Dillhoff M, Dotan E, Ferrone CR, Fisher G, Hardacre J, Hawkins WG, Ko AH, LoConte N, Lowy AM, Moravek C, Nakakura EK, O'Reilly EM, Obando J, Reddy S, Thayer S, Wolff RA, Burns JL, Zuccarino-Catania G.

J Natl Compr Canc Netw. 2019 Mar 1;17(3):202-210. doi: 10.6004/jnccn.2019.0014.

PMID:
30865919
2.

A phase 1, open-label, dose escalation study of intravenous paricalcitol in combination with gemcitabine in patients with advanced malignancies.

Fountzilas C, Javle M, Tan W, Ma Y, Fetterly G, Iyer R, Johnson C.

Cancer. 2018 Oct 1;124(19):3890-3899. doi: 10.1002/cncr.31676. Epub 2018 Oct 9.

PMID:
30299542
3.

Multi-gene Panel Testing in Breast Cancer Management.

Fountzilas C, Kaklamani VG.

Cancer Treat Res. 2018;173:121-140. doi: 10.1007/978-3-319-70197-4_8. Review.

PMID:
29349761
4.

Review: Oncolytic virotherapy, updates and future directions.

Fountzilas C, Patel S, Mahalingam D.

Oncotarget. 2017 May 31;8(60):102617-102639. doi: 10.18632/oncotarget.18309. eCollection 2017 Nov 24. Review.

5.

A phase II trial of erlotinib monotherapy in advanced pancreatic cancer as a first- or second-line agent.

Fountzilas C, Chhatrala R, Khushalani N, Tan W, LeVea C, Hutson A, Tucker C, Ma WW, Warren G, Boland P, Iyer R.

Cancer Chemother Pharmacol. 2017 Sep;80(3):497-505. doi: 10.1007/s00280-017-3375-9. Epub 2017 Jul 12.

PMID:
28702772
6.

A phase II study of REOLYSIN® (pelareorep) in combination with carboplatin and paclitaxel for patients with advanced malignant melanoma.

Mahalingam D, Fountzilas C, Moseley J, Noronha N, Tran H, Chakrabarty R, Selvaggi G, Coffey M, Thompson B, Sarantopoulos J.

Cancer Chemother Pharmacol. 2017 Apr;79(4):697-703. doi: 10.1007/s00280-017-3260-6. Epub 2017 Mar 13.

PMID:
28289863
7.

Clinical characteristics and treatment outcomes of patients with colorectal cancer who develop brain metastasis: a single institution experience.

Fountzilas C, Chang K, Hernandez B, Michalek J, Crownover R, Floyd J, Mahalingam D.

J Gastrointest Oncol. 2017 Feb;8(1):55-63. doi: 10.21037/jgo.2016.12.11.

8.

Risks and benefits of phase I liver dysfunction studies: should patients with severe liver dysfunction be included in these trials?

Fountzilas C, Stuart S, Hernandez B, Bowhay-Carnes E, Michalek J, Sarantopoulos J, Karnad A, Patel S, Weitman S, Mahalingam D.

Invest New Drugs. 2017 Jun;35(3):386-391. doi: 10.1007/s10637-017-0425-4. Epub 2017 Jan 19.

PMID:
28102465
9.

A rare case of ovarian carcinosarcoma with neuroendocrine differentiation.

Dittus C, Fountzilas C, Saha D, Magee A.

J Community Support Oncol. 2014 Feb;12(2):71-4.

PMID:
24971408
10.

Dabigatran overdose secondary to acute kidney injury and amiodarone use.

Fountzilas C, George J, Levine R.

N Z Med J. 2013 Mar 1;126(1370):110-2.

PMID:
23474519
11.

A cerebral mass in a patient with Churg Strauss syndrome.

Ilyas N, Fountzilas C.

N Z Med J. 2011 Sep 9;124(1342):94-7.

PMID:
21963930
12.

Surgical treatment of giant mesenteric fibromatosis presenting as a gastrointestinal stromal tumor: a case report.

Stoidis CN, Spyropoulos BG, Misiakos EP, Fountzilas CK, Paraskeva PP, Fotiadis CI.

J Med Case Rep. 2010 Sep 23;4:314. doi: 10.1186/1752-1947-4-314.

13.

Spontaneous regression of a true splenic cyst: a case report and review of the literature.

Stoidis CN, Spyropoulos BG, Misiakos EP, Fountzilas CK, Paraskeva PP, Fotiadis CI.

Cases J. 2009 Sep 16;2:8730. doi: 10.1186/1757-1626-0002-0000008730.

14.

Diffuse anorectal melanoma; review of the current diagnostic and treatment aspects based on a case report.

Stoidis CN, Spyropoulos BG, Misiakos EP, Fountzilas CK, Paraskeva PP, Fotiadis CI.

World J Surg Oncol. 2009 Aug 11;7:64. doi: 10.1186/1477-7819-7-64.

Supplemental Content

Loading ...
Support Center